Search

everythinglearnresearchcommunity

for

Search:↓

A new imaging technique can observe stem cells in living mice without harming them.

Placental mesenchymal stem cells and their conditioned medium significantly improve healing in local radiation injuries.

Hair from breast cancer patients shows changes in structure and composition, and a test using these changes detected cancer but also falsely identified some healthy samples as cancerous.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

The Bethesda system is effective for identifying thyroid cancer but has low sensitivity.

A 76-year-old man's grey hair turned back to its original color after radiotherapy.

Adipose-derived stem cells and platelet-rich plasma together can protect skin and hair from radiotherapy damage.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Trichoscan® is best for measuring hair growth, RCM for analyzing hair follicles, and OCT is useful for both.

Accurate diagnosis of rare pilomatrix carcinoma is crucial for effective treatment.

NIR-II imaging effectively tracked stem cells that helped repair facial nerve defects in rats.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

ALRN-6924 may prevent hair loss caused by chemotherapy.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Imiquimod 5% cream may not work for treating scrotal extramammary Paget disease.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

AI and new therapies show promise in medicine, especially for cancer and regenerative treatments.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Permanent micropigmentation can help cancer survivors feel better about themselves by restoring eyebrows lost during chemotherapy.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

The study introduced a new imaging technology to track skin healing and bone marrow cell activity over time.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The new hair transplant method improves results and reduces surgery time.

Bortezomib chemotherapy can cause temporary skin rashes.

Tattoo machine-assisted drug delivery may improve hair growth in androgenetic alopecia.

PRP injections with tadalafil and stretching safely improved Peyronie's symptoms but didn't significantly change curvature long-term.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.